Journal of Vaccine Research 2024, Vol.14, No.2, 40-53 http://medscipublisher.com/index.php/jvr 51 Isakova-Sivak I., Matyushenko V., Stepanova E., Matushkina A., Kotomina T., Mezhenskaya D., Prokopenko P., Kudryavtsev I., Kopeykin P., Sivak K., and Rudenko L., 2020, Recombinant live attenuated influenza vaccine viruses carrying conserved T cell epitopes of human adenoviruses induce functional cytotoxic T cell responses and protect mice against both infections, Vaccines, 8(2): 196. https://doi.org/10.3390/vaccines8020196 PMid:32344618 PMCid:PMC7349758 Isakova-Sivak I., Stepanova E., Mezhenskaya D., Matyushenko V., Prokopenko P., Sychev I., Wong P., and Rudenko L., 2021, Influenza vaccine: progress in a vaccine that elicits a broad immune response, Expert Review of Vaccines, 20(9): 1097-1112. https://doi.org/10.1080/14760584.2021.1964961 PMid:34348561 Jang Y.H., and Seong B.L., 2019, The quest for a truly universal influenza vaccine, Frontiers in Cellular and Infection Microbiology, 9: 344. https://doi.org/10.3389/fcimb.2019.00344 PMid:31649895 PMCid:PMC6795694 Jang Y.H., and Seong B.L., 2020, Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection, Expert Opinion on Drug Discovery, 15(12): 1441-1455. https://doi.org/10.1080/17460441.2020.1801629 PMid:32783765 Jansen J.M., Gerlach T., Elbahesh H., Rimmelzwaan G.F., and Saletti G., 2019, Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination, Journal of Clinical Virology, 119: 44-52. https://doi.org/10.1016/j.jcv.2019.08.009 PMid:31491709 Jazayeri S.D., and Poh C.L., 2019, Development of universal influenza vaccines targeting conserved viral proteins, Vaccines, 7(4): 169. https://doi.org/10.3390/vaccines7040169 PMid:31683888 PMCid:PMC6963725 Kim Y.J., Ko E.J., Kim M.C., Lee Y.N., Kim K.H., Jung Y.J., and Kang S.M., 2017, Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection, Biochemical and Biophysical Research Communications, 493(1): 393-398. https://doi.org/10.1016/j.bbrc.2017.09.011 PMid:28887040 PMCid:PMC5636684 Krammer F., and Palese P., 2019, Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain, The Journal of Infectious Diseases, 219(Supplement_1): S62-S67. https://doi.org/10.1093/infdis/jiy711 PMid:30715353 PMCid:PMC6452318 Krammer F., Pica N., Hai R., Margine I., and Palese P., 2013, Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies, Journal of Virology, 87(12): 6542-6550. https://doi.org/10.1128/JVI.00641-13 PMid:23576508 PMCid:PMC3676110 Liebowitz D., Gottlieb K., Kolhatkar N.S., Garg S.J., Asher J.M., Nazareno J., Kim K., McIIwain D., and Tucker S.N., 2020, Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study, The Lancet Infectious Diseases, 20(4): 435-444. https://doi.org/10.1016/S1473-3099(19)30584-5 PMid:31978354 Lo C.Y., Misplon J.A., Li X., Price G.E., Ye Z., and Epstein S.L., 2021, Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice, Vaccine, 39(33): 4628-4640. https://doi.org/10.1016/j.vaccine.2021.06.072 PMid:34226103 Memoli M.J., Han A., Walters K.A., Czajkowski L., Reed S., Athota R., Rosas L., Cervantes-Medina A., Park J., Morens D., Kash J., and Taubenberger J.K., 2020, Influenza a reinfection in sequential human challenge: implications for protective immunity and "universal" vaccine development, Clinical Infectious Diseases, 70(5): 748-753. https://doi.org/10.1093/cid/ciz281 PMid:30953061 PMCid:PMC7319262 Nabel G.J., and Fauci A.S., 2010, Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine, Nature Medicine, 16(12): 1389-1391. https://doi.org/10.1038/nm1210-1389 PMid:21135852 Nachbagauer R., Feser J., Naficy A., Bernstein D.I., Guptill J., Walter E.B., Berlanda-Scorza F., Stadlbauer D., Wilson P., Aydillo T., Behzadi M., Bhavsar D., Bliss C., Capuano C., Carreño J., Chromikova V., Claeys C., Coughlan L., Freyn A., Gast C., Javier A., Jiang K., Mariottini C., McMahon M., McNeal M., Solórzano A., Strohmeier S., Sun W., Wielen M., Innis B., García-Sastre A., Palese P., and Krammer F., 2021, A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial, Nature Medicine, 27(1): 106-114. https://doi.org/10.1038/s41591-020-1118-7 PMid:33288923
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==